首页 › 基金 › Logos Global Management LP › QTTB

Logos Global Management LP 对 QTTB 的持仓历史

Q32 Bio Inc · 医疗保健

Logos Global Management LP 在 Q2 2026 的 13F 申报中披露持有 QTTB(Q32 Bio Inc)800,000 股,市值约 US$10.2M,约占其申报组合的 0.44%,在其申报持仓中市值排名第 48 位。 Logos Global Management LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)800.00K 股
申报持仓市值$10.19M
组合权重0.44%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Logos Global Management LP 对 QTTB 的持仓演变

Logos Global Management LP 于 Q2 2026 首次披露 QTTB 持仓:800,000 股(约 US$10.2M)。

逐季持仓明细

季度股数金额变化
Q2 2026 800.00K $10.19M 新进

关于 QTTB 与 13F 数据

QTTB(Q32 Bio Inc)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 QTTB,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 QTTB 的基金

查看 QTTB 的全部基金持有人 →

常见问题

How long has Logos Global Management LP held QTTB?

Logos Global Management LP has disclosed QTTB holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Logos Global Management LP's current position in QTTB?

As of Q2 2026, Logos Global Management LP holds 800.00K shares of QTTB (Q32 Bio Inc), valued at $10.19M, representing 0.44% of its reported portfolio and ranking #48.

Has Logos Global Management LP been buying or selling QTTB?

In the latest 13F filing (Q2 2026), Logos Global Management LP newly opened its position in QTTB.

Which other funds hold QTTB?

Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.